SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

2015 FDA drug approvals · Study

Work2015 FDA drug approvals

Asher Mullard2016

Work2016

2015 FDA drug approvals

94 citations·0/0 files stored·Nature Reviews Drug Discovery

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Regulation Pharmaceutical industry and healthcare

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 94 citations exist upstream.

References

20152014 FDA drug approvals

Cited by

2025Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2025Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)article · 1 shared reference 2016The Evolving Role of the Medicinal Chemistchapter · 1 shared reference

Details

Year2016

Typeother

Published2016-02-01

VenueNature Reviews Drug Discovery

ISSN-L1474-1776

Languageen

Citations94

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1038/nrd.2016.15

openalex_workW2758474538

Links

Imported from OpenAlex (CC0) — nothing here is generated.